U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Ruxolitinib (Jakavi): CADTH Reimbursement Recommendation: Indication: For the treatment of steroid refractory or dependent acute graft-versus-host disease in patients aged 12 years and older [Internet].

Ruxolitinib (Jakavi): CADTH Reimbursement Recommendation: Indication: For the treatment of steroid refractory or dependent acute graft-versus-host disease in patients aged 12 years and older [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Oct.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...